JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$438M |
| 3 |
Royal Caribbean
RCL
|
+$434M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$432M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$424M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.08B |
| 2 |
Meta Platforms (Facebook)
META
|
+$722M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$721M |
| 4 |
Apple
AAPL
|
+$701M |
| 5 |
Netflix
NFLX
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.51% |
| 2 | Financials | 13.49% |
| 3 | Technology | 11.69% |
| 4 | Healthcare | 10.22% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2651
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.19B
| $1.67M | ﹤0.01% |
38,817
-36,437
| -48% | -$1.45M |
2013 Q2
11 quarters
|
|
|
DEA
2652
Easterly Government Properties
DEA
$1.1B
| $1.66M | ﹤0.01% |
35,780
-520
| -1% | -$22.6K |
2015 Q4
1 quarter
|
|
2653
CALL
General Dynamics
GD
$89.6B
| $1.66M | ﹤0.01% |
12,600
+12,300
| +4,100% | +$1.63M |
2014 Q3
6 quarters
|
|
|
ZYNE
2654
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $1.65M | ﹤0.01% |
174,900
-5,100
| -3% | -$41.1K |
2015 Q4
1 quarter
|
|
2655
CRA International
CRAI
$1.08B
| $1.65M | ﹤0.01% |
84,100
-22,250
| -21% | -$419K |
2015 Q1
4 quarters
|
|
|
MRTX
2656
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.65M | ﹤0.01% |
77,160
+4,135
| +6% | +$92.5K |
2014 Q3
6 quarters
|
|
|
ADMS
2657
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.65M | ﹤0.01% |
114,106
+59,125
| +108% | +$996K |
2014 Q2
7 quarters
|
|
2658
Cirrus Logic
CRUS
$5.96B
| $1.64M | ﹤0.01% |
45,034
-4,479
| -9% | -$145K |
2013 Q2
11 quarters
|
|
2659
Apogee Enterprises
APOG
$835M
| $1.64M | ﹤0.01% |
37,273
+36,991
| +13,117% | +$1.47M |
2015 Q3
2 quarters
|
|
2660
Orion
OEC
$323M
| $1.64M | ﹤0.01% |
+115,879
| New | +$1.46M |
2016 Q1
0 quarters
|
|
|
JONE
2661
DELISTED
Jones Energy, Inc.
JONE
| $1.63M | ﹤0.01% |
26,683
-293
| -1% | -$13.1K |
2014 Q3
6 quarters
|
|
2662
Virtu Financial
VIRT
$5.44B
| $1.63M | ﹤0.01% |
+73,500
| New | +$1.63M |
2016 Q1
0 quarters
|
|
|
BWLD
2663
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $1.62M | ﹤0.01% |
10,964
+426
| +4% | +$65.1K |
2015 Q1
4 quarters
|
|
2664
United Parks & Resorts
PRKS
$1.54B
| $1.62M | ﹤0.01% |
76,796
+76,285
| +14,929% | +$1.43M |
2015 Q4
1 quarter
|
|
2665
Empire State Realty Trust
ESRT
$767M
| $1.61M | ﹤0.01% |
91,729
-409,739
| -82% | -$6.76M |
2014 Q4
5 quarters
|
|
2666
CALL
Williams Companies
WMB
$88.5B
| $1.61M | ﹤0.01% |
100,000
-866,300
| -90% | -$14.9M |
2014 Q3
6 quarters
|
|
2667
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$141M
| $1.6M | ﹤0.01% |
40,646
-38,050
| -48% | -$1.45M |
2013 Q2
11 quarters
|
|
2668
First Trust Technology AlphaDEX Fund
FXL
$2.94B
| $1.6M | ﹤0.01% |
48,596
-46,794
| -49% | -$1.43M |
2014 Q4
5 quarters
|
|
2669
Criteo S.A.
CRTO
$725M
| $1.6M | ﹤0.01% |
38,570
-500
| -1% | -$17.5K |
2014 Q2
7 quarters
|
|
|
SYT
2670
DELISTED
Syngenta Ag
SYT
| $1.6M | ﹤0.01% |
19,272
+397
| +2% | +$31.2K |
2014 Q4
5 quarters
|
|
2671
iShares US Pharmaceuticals ETF
IHE
$1.6B
| $1.59M | ﹤0.01% |
34,800
+12,588
| +57% | +$589K |
2014 Q1
8 quarters
|
|
|
FRAN
2672
DELISTED
Francesca's Holdings Corporation
FRAN
| $1.58M | ﹤0.01% |
6,887
-2,108
| -23% | -$455K |
2015 Q2
3 quarters
|
|
2673
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.94B
| $1.58M | ﹤0.01% |
37,338
+1,180
| +3% | +$47.4K |
2013 Q3
10 quarters
|
|
2674
PUT
Warner Bros
WBD
$77.6B
| $1.57M | ﹤0.01% |
55,000
-107,500
| -66% | -$2.88M |
2015 Q2
3 quarters
|
|
2675
Vanguard FTSE All-World ex-US ETF
VEU
$69.1B
| $1.57M | ﹤0.01% |
36,420
-1,752
| -5% | -$71.8K |
2013 Q2
11 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2016 Portfolio in Review
As of Q1 2016, JP Morgan Chase held 5,307 positions worth $391B, down 1.9% from $398B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2016 filing shows 536 new, 1,742 increased, 1,913 reduced and 585 closed positions. Its largest new stake was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $1.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 20% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2016 buy was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q1 2016, an estimated $2.23B increase.
- JP Morgan Chase's biggest Q1 2016 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $1.08B.
- JP Morgan Chase fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $721M.
- JP Morgan Chase's ten largest holdings make up 17% of its $391B portfolio in Q1 2016.
- JP Morgan Chase opened 536 new positions and closed 585 in Q1 2016.
- JP Morgan Chase's portfolio value fell 1.9% quarter-over-quarter to $391B.
Based on JP Morgan Chase's 13F filing for Q1 2016, filed 10 May 2016.